(1)
Kumar, S.; Mehta, R.; Sah, R. Commentary on “Pembrolizumab in Gestational Trophoblastic Neoplasia: Systematic Review and Meta-Analysis With Sub-Group Analysis of Potential Prognostic Factors. Clinics 2025, 80, 100651. https://doi.org/10.1590/.